Senderra announces Taltz® distribution
Senderra Specialty Pharmacy is proud to announce the availability to Senderra customers of one of the newest treatments for severe plaque psoriasis.
Developed and manufactured by Eli Lilly and Company, Taltz® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light).
“Senderra is committed to working with pharmaceutical companies like Lilly, Prescribers, Payors and Patients to ensure appropriate access to treatments like Taltz® for the improvement of chronic conditions such as psoriasis,” commented Bob Wilburn, Senderra’s newest Senior Vice President of Pharmaceutical Business Development. “We’re pleased to have been selected by Lilly as a part of a limited distrubition panel of specialty pharmacies to fulfill prescriptions for Taltz®.”